Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.120396
Revised: March 30, 2026
Accepted: April 21, 2026
Published online: June 25, 2026
Processing time: 110 Days and 3 Hours
Patients with chronic kidney disease (CKD) are at high risk of developing car
To investigate the association between dialysis modality and cIMT in dialysis patients.
A cross-sectional study of 83 dialysis patients, 40 hemodialysis (HD) patients and 43 peritoneal dialysis (PD) patients, who met the inclusion criteria. Anamnesis, carotid artery ultrasonography (USG), and laboratory tests were performed on all patients. cIMT measurements were performed in 6 carotid territories using ar
PD patients had lower cIMT [0.53 (0.47; 0.67) vs 0.63 (0.54; 0.70); P = 0.005]. Younger age in PD patients was independently associated with lower cIMT (β = 0.006; P = 0.003). PD patients had a lower FGF23/Klotho ratio compared to HD patients [26.26 (13.32; 69.45) vs 67.34 (16.56; 131.35); P = 0.039]. Similarly, in PD patients, a moderate positive correlation was found between calcium, phosphorus, and CaxP product levels with fibroblast growth factor 23 (FGF-23) levels. However, the strength of the correlation was reduced when correlated with the FGF-23/Klotho ratio.
This study showed that PD patients have lower cIMT than HD patients. Younger age was independently associated with lower cIMT. On the other hand, FGF-23 and the FGF-23/Klotho ratio were significantly positively correlated with CaxP product in PD patients, but not in HD patients. Klotho reduces the strength of this correlation, thus appearing play an important role in the lower cIMT in these PD patients.
Core Tip: Chronic kidney disease patients are at high risk of developing cardiovascular disease (CVD). However, traditional risk factors cannot fully predict the incidence of CVD. Carotid artery intima-media thickness (cIMT) is a strong predictor of CVD. There is evidence of a relationship between dialysis modality and cIMT. In this study, peritoneal dialysis (PD) patients were shown to have lower cIMT than HD, making it a preferred option for patients with end-stage renal disease in the context of CVD risk. This may be due to better preservation of residual kidney function, no exposure to dialysis membranes, and the absence of hemodynamic fluctuations in PD patients.